PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0354/2017: EMA decision of 1 December 2017 on the acceptance of a modification of an agreed paediatric investigation plan for telavancin
(hydrochloride) (Vibativ), (EMEA-000239-PIP01-08-M03)